Metabolomics Implicate Eicosanoids in Severe Functional Mitral Regurgitation
ESC Heart Failure · 01.02.2023 · 10 (1) · 311-321
DOI: 10.1002/ehf2.14160 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, online erschienen am 10.10.2022. Verfasst von Thomas M Hofbauer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Failure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund.
Abstract (Originalsprache)
Aims
Secondary, or functional, mitral regurgitation (FMR) was recently recognized as a separate clinical entity, complicating heart failure with reduced ejection fraction (HFrEF) and entailing particularly poor outcome. Currently, there is a lack of targeted therapies for FMR due to the fact that pathomechanisms leading to FMR progression are incompletely understood. In this study, we sought to perform metabolomic profiling of HFrEF patients with severe FMR, comparing results to patients with no or mild FMR. Methods and results Targeted plasma metabolomics and untargeted eicosanoid analyses were performed in samples drawn from HFrEF patients (n = 80) on optimal guideline-directed medical therapy. Specifically, 17 eicosanoids and 188 metabolites were analysed. Forty-seven patients (58.8%) had severe FMR, and 33 patients (41.2%) had no or non-severe FMR. Comparison of eicosanoid levels between groups, accounting for age, body mass index, and sex, revealed significant up-regulation of six eicosanoids (11,12-EET, 13(R)-HODE, 12(S)-HETE, 8,9-DiHETrE, metPGJ2, and 20-HDoHE) in severe FMR patients. Metabolites did not differ significantly. In patients with severe FMR, but not in those without severe FMR, levels of 8,9-DiHETrE above a cut-off specified by receiver-operating characteristic analysis independently predicted all-cause mortality after a median follow-up of 43 [interquartile range 38, 48] months [hazard ratio 12.488 (95% confidence interval 3.835–40.666), P < 0.0001].
Conclusions
We report the up-regulation of various eicosanoids in patients with severe FMR, with 8,9-DiHETrE appearing to predict mortality. Our observations may serve as a nucleus for further investigations into the causes and consequences of metabolic derangements in this important valvular abnormality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Internal Medicine II, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
- Herz Zentrum Waehring, Vienna, Austria.
- Institute of Analytical Chemistry, University of Vienna, Vienna, Austria.
- Joint Metabolome Facility, University of Vienna and Medical University of Vienna, Vienna, Austria.
- Department of Angiology, Internal Medicine II, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Thomas M Hofbauer
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund
Zitieren
APA
Hofbauer, T. M., Distelmaier, K., Muqaku, B., Spinka, G., Seidl, V., Arfsten, H. T., Hagn, G., Meier-Menches, S., Bartko, P. E., Pavo, N., Hoke, M., Prausmueller, S., Heitzinger, G., Pils, D., Lang, I. M., Hengstenberg, C., Hülsmann, M. P., Gerner, C., & Goliasch, G. (2023). Metabolomics Implicate Eicosanoids in Severe Functional Mitral Regurgitation. ESC Heart Failure, 10(1), 311-321. https://doi.org/10.1002/ehf2.14160
Vancouver
Hofbauer TM, Distelmaier K, Muqaku B, Spinka G, Seidl V, Arfsten HT, et al. Metabolomics Implicate Eicosanoids in Severe Functional Mitral Regurgitation. ESC Heart Failure. 2023;10(1):311-321. doi:10.1002/ehf2.14160
BibTeX
@article{Hofbauer2023,
author = {Hofbauer, Thomas M and Distelmaier, Klaus and Muqaku, Besnik and Spinka, Georg and Seidl, Veronika and Arfsten, Henrike T and Hagn, Gerhard and Meier-Menches, Samuel and Bartko, Philipp E and Pavo, Noemi and Hoke, Matthias and Prausmueller, Suriya and Heitzinger, Gregor and Pils, Dietmar and Lang, Irene M and Hengstenberg, Christian and Hülsmann, Martin P and Gerner, Christopher and Goliasch, Georg},
title = {Metabolomics Implicate Eicosanoids in Severe Functional Mitral Regurgitation},
journal = {ESC Heart Failure},
year = {2023},
volume = {10},
number = {1},
pages = {311--321},
doi = {10.1002/ehf2.14160}
}
EUVIMED